Conquering Schistosomiasis In China: The Last Mile
Funder
National Health and Medical Research Council
Funding Amount
$2,432,780.00
Summary
Schistosomiasis (Bilharzia), caused by Schistosoma bloodflukes, is an ancient disease in the People’s Republic of China (PRC). After decades of control, the Chinese authorities have slated their intention to eliminate the disease by 2020. However, current diagnostic methods underestimate the true infection rates so we contend this target is unattainable. Supplementation of current control measures with additional public health interventions will be required to achieve the goal of elimination.
Genomic-based Tools To Support The Control Of Urogenital Schistosomiasis And Hepatic Opisthorchiasis
Funder
National Health and Medical Research Council
Funding Amount
$419,180.00
Summary
Over 100 million people are affected by parasitic flukes that promote malignant tumours. Parasite control depends on a single drug, making resistance an imminent threat. I will deliver new genomic tools to unravel the complex interactions between parasites and humans, and explore parasite population diversity on a continental scale. I will then prioritise a panel of anti-parasitic drug targets and vaccine candidates to deliver the next generation of interventions against parasitic diseases.
Genome-based Tools To Support Urogenital Schistosomiasis Control
Funder
National Health and Medical Research Council
Funding Amount
$429,644.00
Summary
More than 100 million sub-Saharan Africans have urogenital schistosomiasis, a disease that promotes malignant cancer and HIV/AIDS. Control depends on a single drug, making resistance an imminent threat. We will deliver new molecular tools to assess parasite genetic diversity and to prioritise a panel of anti-parasitic drug targets and vaccine candidates. These outcomes will deliver the next generation of interventions against urogenital schistosomiasis.
Targeting Schistosome Calcium Signalling To Improve And Broaden Praziquantel Efficacy
Funder
National Health and Medical Research Council
Funding Amount
$481,661.00
Summary
Schistosomiasis is caused by parasitic worms, treatment relies solely on praziquantel (PZQ). Schistosomes respond and recover from PZQ exposure through modulation of the gene CamKII. We will target this gene to both increase and extend the efficacy of PZQ in both adult parasites and in refractory juvenile parasites. Research will expand into assaying CamKII inhibitors to maximise effectiveness and take this work into animal models of this disease.
Elimination Of Zoonotic Schistosomiasis And Echinococcosis Through Integrated Morbidity Control
Funder
National Health and Medical Research Council
Funding Amount
$898,008.00
Summary
I am a parasitologist researching the biology, immunology and epidemiology of human parasitic worms, particularly the schistosome bloodflukes and the hydatid tapeworms, which cause bilharzia and hydatidosis, diseases of the world’s poorest people that cause both major suffering and economic loss. My goal is to develop new methods, including vaccination, to control and eventually eliminate these parasites.
Parasitic infections are a significant global health problem, resulting in more than a million deaths annually. Unfortunately there is no licensed vaccine available for any human parasitic infection, and in many cases current drugs suffer from issues of parasite drug resistance. To address this problem this project brings together leading researchers from the European Union, Brazil, and Australia to discover and develop new types of drugs for four major human parasitic diseases: schistosomiasis, ....Parasitic infections are a significant global health problem, resulting in more than a million deaths annually. Unfortunately there is no licensed vaccine available for any human parasitic infection, and in many cases current drugs suffer from issues of parasite drug resistance. To address this problem this project brings together leading researchers from the European Union, Brazil, and Australia to discover and develop new types of drugs for four major human parasitic diseases: schistosomiasis, leishmaniasis, Chagas disease and malaria.Read moreRead less
Unravelling The Tetraspanin Web In The Schistosome Tegument.
Funder
National Health and Medical Research Council
Funding Amount
$309,537.00
Summary
Infection with the human blood fluke, Schistosoma mansoni, is a major human ailment affecting almost 200 million people world wide and causing approximately 200 000 deaths per year. Current control efforts rely on anthelminthic drugs but, to sustain their effects, they must be applied for an indefinite period of time due to reinfection. This project will extend recent efforts to develop a vaccine for this organism and decrease the public health burden and mortality associated with infection.
Impact Of The Three Gorges Dam On Transmission And Future Control Of Human Schistosomiasis In China
Funder
National Health and Medical Research Council
Funding Amount
$1,420,135.00
Summary
A million Chinese have schistosomiasis or snail fever. When the Three Gorges Dam on the Yangtze River is fully operational, considerable environmental-ecological changes will result, increasing spread of this parasitic disease. In a unique study we will assess the impact of the Dam on schistosomiasis, and test and model a series of options for its control. The findings will be important for China and other areas where schistosomiasis occurs and where similar dams are planned or are under way.
Apical Membrane Proteins As Targets For A Schistosomiasis Vaccine
Funder
National Health and Medical Research Council
Funding Amount
$480,459.00
Summary
Schsitosomiasis is a chronic neglected tropical disease for which there is currently no vaccine. A vaccine is sorely needed to control this parasite. This proposal seeks to identify molecules from the outer surface of the parasite which are recognised by the immune system of people from Brazil who are resistant to schistosomiasis. Molecules identified in this manner will be tested as vaccines in an animal model of schistosomiasis, and ranked based on their performances to enter human trials.
Schistosomiasis is a major public health problem in the Philippines with approximately 6.7 million people at risk of infection. Mass human chemotherapy has formed the cornerstone of control for decades but has failed to control the disease. Transmission reduction is a key step towards elimination and integrated interventions should target both definitive and intermediate host transmission pathways. We propose to trial integrated control strategies for the disease and expect the outcomes to have ....Schistosomiasis is a major public health problem in the Philippines with approximately 6.7 million people at risk of infection. Mass human chemotherapy has formed the cornerstone of control for decades but has failed to control the disease. Transmission reduction is a key step towards elimination and integrated interventions should target both definitive and intermediate host transmission pathways. We propose to trial integrated control strategies for the disease and expect the outcomes to have broader implications for Southeast Asia.Read moreRead less